Different influences on internal exposure to platinum are investigated and for the first time weighted in environmentally exposed subjects as far as individual internal platinum concentrations are concerned. Detailed medical and environmental histories as well as oral cavity status were assessed in 84 dermatological patients, and internal platinum exposure was determined by analyzing platinum in urine using adsorptive voltammetry ( AV ). Platinum concentrations ranged from < 0.9 ( detection limit ) to 65.5 ng Pt / l urine. Influence of different types and age of alloy restorations and therefore relevance of the exposure pathway due to solubilization of platinum in saliva could be demonstrated. No platinum -related health effects ( contact stomatitis, asthma or kidney conditions ) were observed. Analysis of covariance showed the number of noble dental alloy restorations ( P < 0.0001 ) and to a lesser extent age ( P= 0.0017 ) to independently influence internal platinum exposure. Even though spread of environmental platinum has increased, internal platinum exposure is low in subjects without assessable medical or dental devices ( usually < 4.5 ng / l urine ) and not related to adverse health effects. For the first time, detailed individual information on possible exposure pathways to platinum were considered in an analysis of relevant influential factors: Car traffic exposure and dermatological condition showed no association with internal platinum exposure. Uptake from platinum containing noble metal dental alloy restorations ( NMDAR ) is of greatest relevance, surmounting the influence of each year of lifetime on platinum body load by more than 10 -fold.
Introduction
Since the introduction of automotive catalytic converters containing platinum, the input of this precious metal into the environment has rapidly increased ( Helmers and Mergel, 1997; Becker et al., 2000 ) . Automotive catalytic converters with exhaust fumes containing platinum group elements (PGE ) have become the main source of environmental urban pollution from platinum group metals. Platinum emission is estimated to be about 200-300 ng/driven kilometer (Artelt et al., 1999; Zereini and Alt, 1999 ) , but there have also been higher estimations (Helmers and Mergel, 1997 ) . Emission is positively correlated to high speed (Helmers and Mergel, 1997 ) and new catalytic converters ( Palacios et al., 2000) . Platinum and palladium contents in surface soil have been shown to decrease exponentially with increasing distance from highways (Mueller and Heumann, 2000) , but these metals can also be transported to urban rivers through run -off water ( Rauch and Morrison, 1999 ) .
Most of the platinum from the catalytic converters is liberated as particle -bound metal, of which most particles are >10.2 m ( Artelt et al., 1999 ) . The fraction passing through the lung varies between 11% and 36%. Emission of soluble and therefore possibly toxic platinum is estimated to be about 1% (Artelt et al., 1999 ) . Occupationally related uptake of platinum by inhalation from car traffic seems to be of no relevance as far as internal exposure is concerned (Begerow et al., 1999a; Farago et al., 1998 ) .
Data on human internal exposure to environmental platinum is nevertheless scarce. Depending on the analytical method applied and the study group, different levels of platinum in urine have been reported (Table 1 ) (Weber et al., 1991; Ensslin et al., 1994; Schierl et al., 1994 Schierl et al., , 1998 Schramel et al., 1995; Begerow et al., 1996 Begerow et al., , 1997 Begerow et al., , 1999a Farago et al., 1998; Philippeit and Angerer, 1999; Schierl, 2001 ) . To date, it is not known to what extent different exposure pathways and the chemical species influence the platinum concentration in environmentally exposed humans. It has been shown to be related to the workplace, for example, dental and precious metal work. Studies concerning road workers have not shown a higher internal platinum exposure due to these workplaces (Farago et al., 1998 ) . Noble metal dental alloy restorations ( NMDAR ) are known to vary and to contain up to 20% platinum depending on the type of restoration and the composition of the alloy ( Bundeszahnaerztekammer and Kassenzahnaerztliche Bundesvereinigung, 1998 ) and therefore influence the internal platinum exposure ( Table 2 ) probably after oral uptake of metal platinum (Philippeit and Angerer, 1999; Schierl, 2001 ) .
Regarding toxicology and sensitization, platinum emitted in metallic or oxide form is considered to be biologically inert and non -allergenic ( Farago et al., 1998 ) . Although platinum from road dusts can be solubilized and enter water, sediment, soil and the food chain, there is at present no evidence for an adverse health effect, particularly allergenic, from platinum in the general environment (Farago et al., 1998 ) . Adverse health effects such as dermatitis and asthma are related to occupational exposure to platinum salts and nephrotoxicity and carcinogenicity to cancer medication with cisplatin (IARC, 1987; Merget et al., 1999; Newman Taylor et al., 1999; Sato et al., 2000 ) . Contact stomatitis due to sensitization to palladium and, to a lesser extent, to platinum in NMDAR has been described (Koch and Baum, 1996 ) . Table 1 shows a limited number of subjects that have been investigated in studies addressing internal exposure to environmental platinum. Most of the studies performed before concerned occupational platinum exposure. For the 84 subjects reported here, the exact individual number of dental alloy restorations as well as exposure to car traffic and other personal data (age, gender, medical histories) were considered when investigating possible influences on internal platinum exposure, for the first time.
Materials and methods

Study Group
In this study, internal exposure to platinum was studied in 84 patients with atopic dermatitis or psoriasis. In addition to comparing internal exposure in these two disease groups, the study aimed to seek out factors associated with environmental exposure to platinum.
All inpatients of the TOMESA -Clinic for Allergy, Skin and Joint Diseases and Rheumatism between February 1998 and November 1999 aged 15 years and above had the opportunity to participate in the study. They were informed by their doctors about the study upon being admitted to the hospital. After having given their written consent, they received a special environmental questionnaire and instructions on collecting urine for 24 h.
Environmental Health Data
After having completed this modified version of the questionnaire also used in the Environmental Outpatients Department of the Institute for Hygiene and Environmental Medicine of the University in Giessen, all participants were interviewed by one medical student. The aim of the questionnaire was to assess their complete medical, work, leisure time, nutrition, and smoking history. A special emphasis was laid upon health effects possibly related to platinum salts and platinum medication: dermatitis and asthma as well as kidney conditions and neoplasms (IARC, 1987; Merget et al., 1999; Newman Taylor et al., 1999; Sato et al., 2000 ) . Having been trained by a dentist, the interviewer also inspected their dental status as far as number and type of dental alloy restorations were concerned. The oral cavity was also examined in detail with regard to mucous membranes especially contact stomatitis (Koch and Analysis of variance showed influence of age on concentrations of platinum in urine ( P= 0.0004 in the study group and in the subgroup without NMDAR P= 0.0017 ). d Analysis of variance showed no influence of distance of home from a busy road on concentrations of platinum in urine.
e Analysis of variance showed no influence of gender on concentrations of platinum in urine. f Analysis of variance showed no influence of smoking: yes, no and during the past 5 years on concentrations of platinum in urine. g Analysis of variance showed no influence of dermatological condition: atopic dermatitis ( atopic ) or psoriasis ( psoriatic ) on concentrations of platinum in urine. Baum, 1996 ) . With these data, it was possible to characterize each participant as far as an environmental exposure to platinum was concerned: number of NMDAR, distance of the home to a busy road. It was also assessed whether they met the exclusion criteria: workplace with contact to precious metals, especially platinum, and previous cancer medication containing platinum.
Sample Collection, Preparation and Analysis Urine was collected by each patient during 24 hours. It was collected in polyethylene bottles ( contents 2 l ), which were previously washed in a dishwasher and rinsed with citric acid. Directly after collecting, the urine was aliquoted in 100ml -portions, acidified with acetic acid and stored at À 188C. Determination of platinum was carried out according to a method of Messerschmidt et al. (1992 ) by means of adsorptive inverse voltammetry in the differential pulse mode ( DPP ) using the standard addition procedure. After complete removal of the biological matrix by UV digestion, platinum in oxidation state +II was converted to a formazone complex by addition of formaldehyde and hydrazine. This complex is enriched by adsorption on a hanging mercury drop for a specified, brief period of time. The current peak was recorded when the voltage was continuously adjusted in the cathodic direction. Calibration was carried out using aqueous solutions of a commercially available platinum standard which were added to the assay solution in increasing quantities. The limit of detection ( LOD ) was 0.9 ng /Pt / l urine. Contamination of all reagents used was proven. Blank reagent values were found to be below 1 ng /l in all cases.
The procedure is described consecutively in more detail: For analysis, 1 ml urine, 5 ml ultrapure water, 100 l sulfuric acid ( 96%, Merck suprapur ) and 200 l hydrogen peroxide (30%, Merck suprapur ) in special quartz vessels were irradiated 2 h in a 705 UV Digestor (Metrohm ). A smaller proportion of urine was taken if its creatinine concentration was found to be higher than 1.5 g /l or nonspecific matrix problems occurred. After photolysis, the total sample was poured into a voltammetric vessel, 1 ml of an aqueous solution of hydrazine and formaldehyde was added, and the solution was analyzed by means of adsorptive inverse voltammetry. Urine specimens were determined along with urine -based quality control materials to evaluate accuracy. The target value of the certified reference material was 44.7 ng Pt /l. On eleven different days, values between 41.6 and 48.5 ng Pt /l were obtained. The standard deviation was 2.2 and the relative standard deviation was 4.8%.
Statistical Analysis
This study centers on investigating and weighing the different factors influencing the excretion levels in environmentally exposed subjects. NMDAR and car traffic as well as age, gender, smoking habits and the two dermatological conditions (atopic dermatitis and psoriasis ) were considered as possible hypothetical influences. To assess the effects of certain covariates on the platinum concentration in urine, an analysis of covariance was performed. The skewed data of the platinum measurements in urine followed a lognormal distribution and a log -transformation produced approximate normality. Measurements below the detection limit were replaced by LOD /2. Confounders considered were the distance of the home from a busy road ( < 50 m vs. >50 m ) representing exposure to car traffic ( Ranft, 1994 ) , the number of NMDAR and age both entered as continuous data, smoking status ( non -smoking >5 years vs. smoking at present or in the past 5 years ) and the dermatological condition (atopic dermatitis vs. psoriasis ). The General Linear Model (GLM ) procedure of the statistical package SAS (Version 8.0) was used for the analysis.
Results
Study Group
Due to some missing data, the number of patients taken into account ranges between 81 and 84 ( Table 2 ). All 84 members of the study group were at least 15 years of age and 32 of them reported having 1 -14 NMDAR. Kidney disorders were never reported. The regular intake of medicaments was also assessed. No present or previous intake of any platinum -containing medication ( e.g. cytostatic medication ) was stated by the study subjects. It was not possible to find out though to what extent the medication reported comprised formulas containing traces of platinum as residues of synthesis, as there is insufficient specific data on such residues. When the individual medical history was taken, 63% of all 84 patients reported allergies. All had consulted a specialist for dermatology previously (four contact allergies reported concerned nickel, one cobalt, two potassium dichromate, one copper salts and two methyl mercury in eight patients altogether ). No one reported contact allergy to platinum or other precious metals. The inspection of the oral cavity did not lead to pathological findings, for example, contact stomatitis in any study subject either. Concerning dental status, no one had reported having NMDAR removed in the past but two had received these restorations within the last 14 months. One person had 14 NMDAR, 12 of which were capped by a ceramic crown. He was considered as having 14 NMDAR in the statistical analysis, because not the type but the more reliable characteristic: number of NMDAR entered the analysis. One subject was fitted with two pivot teeth and reported a hip operation.
Internal Platinum Exposure
The overall content of platinum in urine varied from below detection limit to 65.5 ng /l. Participants without NMDAR showed a median of <0.9 ng Pt /l urine and a maximum of 13.8 ng Pt /l urine (Table 2 ). This maximum platinum concentration was seen in a woman aged 78 years reporting two pivot teeth and a hip operation in her medical history. Therefore, in subjects without assessable metal medical or dental devices, a maximum concentration of < 4.5 ng /l was found.
In the subgroup with dental NMDAR, the woman with the highest internal platinum exposure (65.5 ng/l ) reported receiving these six NMDAR in exchange of amalgam restorations within the last 14 months. The subject with an internal platinum exposure of only 2.9 ng /l urine, on the other hand, reported the highest number of NMDAR ( n= 14), but 12 of these were ceramic covered.
Statistical Analysis of Internal Platinum Exposure
The analysis of covariance of internal platinum exposure mentioned above ( Table 2 ) was able to explain about 53% of the variability of platinum content in urine, P < 0.0001 ( estimate 0.3066 95% CI 0.2268; 0.3864 ). It could be shown that age influenced the platinum content in urine independently of NMDAR P= 0.0017 ( estimate 0.026 95% CI 0.0081; 0.033; Table 2 ). An effect on internal platinum exposure could not be demonstrated for the other confounders.
In the basic model, each further NMDAR assessed increased the platinum content in urine by about 35%, which is the strongest influencing factor found and can be estimated as increase of about 0.579 ng Pt /l urine /NMDAR considering the geometric mean of 1.1655 ng Pt / l urine found in this study group. In the analysis of the subgroup without NMDAR, each year of increasing age led to a much lower increase of only about 2.08% or an estimated 0.015 ng Pt /l urine / year of life.
Discussion
Concentrations of platinum in urine were comparable to previous environmental studies showing medians generally < 1.5 ng Pt /l urine or means generally < 6 ng Pt /l urine as well as single cases of higher platinum levels ( Table 1) . Although the presented sample comprises patients with dermatological conditions, this is not considered to bias the internal platinum exposure found.
For instance, the sample studied by Philippeit and Angerer ( 1999 ) not comprising dermatological patients can be looked upon as a reference sample for the presented data on dermatological patients as urine of both groups were analyzed identically in the same laboratory. The maximum, median and mean concentrations are lower in the presented study group. This difference is due to the very high concentrations these authors report in subjects carrying NMDAR ( Table 1 ) . Unfortunately, the exact number of NMDAR is not assessed. This might have served to explain their higher concentrations. Other environmental studies published so far, also did not assess the exact number of NMDAR minutely. Even though it has been demonstrated that urine levels of subjects with NMDAR are about 20 times that of those without these dental materials (Philippeit and Angerer, 1999 ) , it could be shown here for the first time that internal platinum exposure is higher in study groups reporting NMDAR and also increases with their number (Table 2 ) .
Higher levels of platinum in saliva have been reported in association with NMDAR. Data of two subjects studied here also give evidence that platinum in NMDAR is taken up from platinum solubilized in saliva from the oral surfaces of the restorations. The person with highest internal platinum exposure reported having received six NMDAR within the last 14 months. Recently inserted NMDAR release more metal than older fillings. It has been shown that urinary platinum levels rise immediately after placement of NMDAR (Hugger et al., 2000; Begerow et al., 1999b ) . The subject with the largest number of NMDAR, on the other hand had a very low internal platinum exposure, as 12 of her 14 NMDAR were covered by ceramic, therefore releasing less platinum into the saliva. This points at the relevance of different compositions and types of dental alloy restorations as far as individual external exposure is concerned. These were not assessable in the scope of the clinical dental examination of this study though. Therefore, only the number of dental restoration, which can be considered the most reliably detectable exposure due to dental material, entered the statistical analysis of internal platinum exposure.
Occupational studies on health care and road workers also report similarly low platinum mean and median levels as mentioned above. Higher concentrations are only reported in workers in the precious metal and catalytic converter industry ( Table 1) . Dental technicians are also reported to have a greater internal exposure to platinum.
Data concerning the toxicity of platinum are scarce (IARC, 1987; Merget et al., 1999; Newman Taylor et al., 1999; Sato et al., 2000 ) , occupational threshold levels aim at preventing pulmonary or skin impairment in workers in contact with platinum salts ( Renner and Schmuckler, 1991 ) . Presently, environmental exposure is not considered to cause adverse health effects ( Farago et al., 1998; Santucci et al., 2000 ) . This is underlined by the presented data as platinum levels determined in this study group were comparable to levels described by others in environmental health studies of healthy subjects. As could have been expected, health disturbances attributable to ingested or inhalational platinum exposure, for example, kidney disorders, neoplasms and asthma, were not found. Skinrelated disorders and sensitizations ( other than atopic dermatitis and psoriasis ) were also not found, although this was looked into in depth as the subjects were inpatients in a highly specialized clinic. The same applies for contact stomatitis, described in association with NMDAR (Koch and Baum, 1996 ) . Internal platinum exposure also did not differ depending on the dermatological condition ( atopic dermatitis or psoriasis ), when the number of NMDAR was considered in the data analysis (Table 2 ) . Any evidence concerning dermatological conditions (e.g. platinosis ) and platinum is restricted to observations in occupational settings and skin contact with platinum salts (Santucci et al., 2000 ) .
The design of the study not only made it possible to describe health and oral status minutely but also to assess environmental exposures, for example, external exposure to traffic exhaust in each subject. As in previous studies concerning workers exposed to car traffic, there was no evidence that car traffic influences internal platinum exposure ( Farago et al., 1998; Begerow et al., 1999a ) . In this study, the participants were considered to be exposed to car traffic if they reported their home to be closer than 50 m to a busy road. This has been proposed by others to be a relevant distance for external exposure to environmental car exhausts ( Ranft, 1994 ) . Obviously increasing concentrations of platinum found in environmental samples ( Helmers and Mergel, 1997; Artelt et al., 1999; Rauch and Morrison, 1999; Zereini and Alt, 1999; Becker et al., 2000; Mueller and Heumann, 2000; Palacios et al., 2000 ) near places with high traffic density do not directly influence the internal exposure. Uptake of relevant amounts of platinum by inhalation seems to occur only when there is direct contact, for instance, while working with the salts of this precious metal (Weber et al., 1991; Farago et al., 1998 ) .
It is unclear whether platinum levels increase over lifetime (Schierl et al., 1998; Begerow et al., 1999a ) . The half -life of inhaled platinum was estimated in workers in the platinum industry ( Schierl, 1999 ) : After inhalational exposure to complex platinum salts, a first half -life of 50 h [ 36-66 h ], and a second half -life of 24 days [18 -33 days ] due to higher inhalational exposure were observed. Animal experiments also show similar biphasic kinetics with a short first half -life of about 1 day, followed by a longer half -life of about 10 days (Durbin, 1960; Moore et al., 1975 ) . Studies concerning chemotherapy with cis -and carboplatin, which are difficult to compare to studies concerning metal inhalation, have indicated accumulation of platinum in the liver with elevated platinum content in urine 2 years after the end of therapy (Tothill et al., 1992 ) . In another study concerning long -term excretion of platinum following chemotherapy with cisplatin, two biological half -lives of 160 and 720 days were calculated; urinary platinum concentrations determined at 8 years after cisplatin therapy were 40 times higher than the background level ( Schierl et al., 1995 ) . Interindividual differences in metabolism and in half -life have been described for these substances ( Gamelin et al., 1995 ) . Workers formerly exposed to platinum still show a 25 -fold platinum excretion after several years. It remains unclear, whether these individuals were occupationally exposed to platinum salts or metallic platinum (Begerow et al., 1999a; Schierl et al., 1998 ) .
It was observed here for the first time that internal platinum excretion in environmentally exposed individuals without NMDAR or previous platinum medication is age dependent ( Table 2 ) , also demonstrated in the rising medians in stratified age groups ( Table 2 ) . Even when one subject reporting a previous hip operation and pivot teeth was excluded in the analysis (data not shown ), age still showed an influence. Another study considering 17 environmentally exposed subjects did not find this age dependency of platinum excretion ( Begerow et al., 1999a ) . The question must be raised and addressed in future studies though, whether platinum actually does accumulate over lifetime, as indicated in the present analysis or whether dental and medical devices, in some subjects not assessable, simulate this effect.
In this study, different parameters possibly influencing internal exposure to environmental platinum were assessed and their influence on body load was analyzed simultaneously ( Table 2 ) for the first time. The presented data showed the increasing number of NMDAR as having the strongest influence on the body load of platinum in environmentally exposed population. This can be estimated as surmounting the influence of each year of lifetime on platinum body load and possibly other non-medical implants not assessed here by more than 10-fold. In addition to previous studies (Begerow et al., 1999a; Philippeit and Angerer, 1999 ) , it could be shown here that there is also a positive correlation between the exact number of NMDAR and the concentration of platinum in urine. Furthermore, platinum has to be solubilized in saliva from the NMDAR to be taken up as numerous ceramic -crowned NMDAR (n =14! ) resulted in low platinum excretion.
The presented data of one of the largest environmentally exposed study groups assessing health status and environmental exposure show that higher concentrations of platinum in urine ( >4.5 ng/ l) were associated with dental or medical devices. These are often difficult to assess and may simulate unexplainable interindividual differences in internal platinum exposure. Increasing age showed a minute influence. The present internal platinum exposure in the general population does not seem to lead to demonstrable health effects.
